A class of atypical antidepressants that exert their effects by antagonizing presynaptic alpha2 receptors of both noradrenergic and serotonergic neurons, resulting in enhanced neurotransmission of norepinephrine and serotonin. NaSSAs are used primarily for the treatment of depression and anxiety disorders. An example of an NaSSA is mirtazapine (remeron).